Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Successful Drill Program at Nevada Gold Project points toward Mine Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aclarion Inc ACON

Healthcare Biotechnology
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the... see more

Recent & Breaking News (NDAQ:ACON)

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

GlobeNewswire August 15, 2024

Aclarion Announces First Commercial Agreement in Michigan

GlobeNewswire August 14, 2024

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

GlobeNewswire August 13, 2024

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

GlobeNewswire July 9, 2024

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

GlobeNewswire June 26, 2024

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

GlobeNewswire June 25, 2024

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

ACCESS Newswire April 29, 2024

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

GlobeNewswire April 25, 2024

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

GlobeNewswire March 4, 2024

Aclarion Announces Closing of $3.0 Million Public Offering

GlobeNewswire February 27, 2024

Aclarion Announces Pricing of $3.0 Million Public Offering

GlobeNewswire February 26, 2024

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

GlobeNewswire February 5, 2024

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?

PR Newswire January 29, 2024

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

GlobeNewswire January 22, 2024

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

GlobeNewswire January 17, 2024

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

GlobeNewswire January 8, 2024

Aclarion Announces Reverse Stock Split

GlobeNewswire January 2, 2024

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

GlobeNewswire November 27, 2023

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

GlobeNewswire November 8, 2023

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

GlobeNewswire November 6, 2023